These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26399335)

  • 1. Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
    Temma J; Matsuhisa M; Horie T; Kuroda A; Mori H; Tamaki M; Endo I; Aihara K; Abe M; Matsumoto T
    J Med Invest; 2015; 62(3-4):126-9. PubMed ID: 26399335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.
    Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I
    J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.
    Osawa S; Katakami N; Kuroda A; Takahara M; Sakamoto F; Kawamori D; Matsuoka T; Matsuhisa M; Shimomura I
    J Atheroscler Thromb; 2017 Mar; 24(3):312-326. PubMed ID: 27592627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
    Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
    Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study.
    Yoshioka K
    Diabetes Ther; 2018 Feb; 9(1):75-85. PubMed ID: 29177923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
    Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
    J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
    Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
    J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
    Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.
    Ueno H; Koyama H; Fukumoto S; Tanaka S; Shoji T; Shoji T; Emoto M; Tahara H; Inaba M; Kakiya R; Tabata T; Miyata T; Nishizawa Y
    Metabolism; 2011 Apr; 60(4):453-9. PubMed ID: 20494372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease.
    Irie Y; Katakami N; Kaneto H; Kasami R; Sumitsuji S; Yamasaki K; Tachibana K; Kuroda T; Sakamoto K; Umayahara Y; Ueda Y; Kosugi K; Shimomura I
    Atherosclerosis; 2012 Apr; 221(2):438-44. PubMed ID: 22321873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.
    Chen L; Yang Z; Lu B; Li Q; Ye Z; He M; Huang Y; Wang X; Zhang Z; Wen J; Liu C; Qu S; Hu R
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):766-70. PubMed ID: 21609350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
    Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
    J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative Groups.
    Dadoniene J; Cypiene A; Ryliskyte L; Rugiene R; Ryliškiene K; Laucevičius A
    Dis Markers; 2015; 2015():837470. PubMed ID: 26880854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.